J Pediatr Genet 2022; 11(04): 313-316
DOI: 10.1055/s-0040-1719054
Case Report

A Case Report: Two Young Children with Long QT Syndrome Type-2 Diagnosed by Presymptomatic Genetic Testing

1   Department of Pediatrics, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan
,
Hazumu Nagata
2   Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
,
3   Research Center for Environmental and Developmental Medical Sciences, Kyushu University, Fukuoka, Japan
,
Sawako Shikada
4   Department of Clinical Genetics and Medicine, Kyushu University Hospital, Fukuoka, Japan
,
5   Omics Research Center, National Cerebral and Cardiovascular Center, Suita, Japan
,
5   Omics Research Center, National Cerebral and Cardiovascular Center, Suita, Japan
› Author Affiliations

Abstract

Long QT syndromes (LQTSs) can lead to sudden cardiac death, yet these syndromes are often asymptomatic and clinically undetected, despite the prolongation of the QT interval. Currently, when a disease-causing variant is identified in an individual, presymptomatic genetic testing is available and can form part of the recommended cascade testing to identify other family members at risk. We herein report the cases of two daughters who received presymptomatic genetic testing in infancy when the proband mother had been diagnosed with LQTS type 2 (LQT2; c.1171C > T, p.Q391X in KCNH2) after suffering from cardiac arrhythmia at 30 years of age. The daughters had a normal QTc interval, but they carried the same disease-causing variant as their mother. Children with family members who have genetically confirmed LQTS have a high risk of suffering from cardiac events later in life, so genetic testing is required. This poses a complex problem, as guidelines for medical intervention and follow-up systems among asymptomatic children with LQTS have yet to be established. Genetic testing should only be performed after adequate counseling to support children later in life. Individualized long-term genetic counseling is required for both parents and children at stages throughout life.

Ethical Statement

This study was performed in accordance with the recommendations of the Ethics Review Committee of the Nagasaki University Graduate School of Biomedical Sciences, and the protocol was approved by this committee. All patients gave their written informed consent, except in the case of minors, where written informed consent was obtained from their parents, in accordance with the Declaration of Helsinki.




Publication History

Received: 06 August 2020

Accepted: 26 September 2020

Article published online:
23 November 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Richards S, Aziz N, Bale S. ACMG Laboratory Quality Assurance Committee. , et al; Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
  • 2 Benatar A, Decraene T. Comparison of formulae for heart rate correction of QT interval in exercise ECGs from healthy children. Heart 2001; 86 (02) 199-202
  • 3 Schwartz PJ, Crotti L. QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation 2011; 124 (20) 2181-2184
  • 4 Priori SG, Schwartz PJ, Napolitano C. , et al. Risk stratification in the long-QT syndrome. N Engl J Med 2003; 348 (19) 1866-1874
  • 5 Zareba W, Moss AJ, Locati EH. International Long QT Syndrome Registry. , et al; Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. J Am Coll Cardiol 2003; 42 (01) 103-109
  • 6 Schwartz PJ, Ackerman MJ, George Jr AL, Wilde AAM. Impact of genetics on the clinical management of channelopathies. J Am Coll Cardiol 2013; 62 (03) 169-180
  • 7 Shimizu W, Moss AJ, Wilde AA. , et al. Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol 2009; 54 (22) 2052-2062
  • 8 Shimizu W, Makimoto H, Yamagata K. , et al. Association of genetic and clinical aspects of congenital long QT syndrome with life-threatening arrhythmias in japanese patients. JAMA Cardiol 2019; 4 (03) 246-254
  • 9 Spazzolini C, Mullally J, Moss AJ. , et al. Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy. J Am Coll Cardiol 2009; 54 (09) 832-837
  • 10 Seth R, Moss AJ, McNitt S. , et al. Long QT syndrome and pregnancy. J Am Coll Cardiol 2007; 49 (10) 1092-1098
  • 11 Yoshinaga M, Ushinohama H, Sato S. , et al. Electrocardiographic screening of 1-month-old infants for identifying prolonged QT intervals. Circ Arrhythm Electrophysiol 2013; 6 (05) 932-938
  • 12 Miyazaki A, Sakaguchi H, Matsumura Y. , et al. Mid-term follow-up of school-aged children with borderline long QT interval. Circ J 2017; 81 (05) 726-732
  • 13 Giudicessi JR, Ackerman MJ. Genotype- and phenotype-guided management of congenital long QT syndrome. Curr Probl Cardiol 2013; 38 (10) 417-455
  • 14 Ormondroyd E, Oates S, Parker M, Blair E, Watkins H. Pre-symptomatic genetic testing for inherited cardiac conditions: a qualitative exploration of psychosocial and ethical implications. Eur J Hum Genet 2014; 22 (01) 88-93
  • 15 Millat G, Chevalier P, Restier-Miron L. , et al. Spectrum of pathogenic mutations and associated polymorphisms in a cohort of 44 unrelated patients with long QT syndrome. Clin Genet 2006; 70 (03) 214-227